105 related articles for article (PubMed ID: 35849868)
1. Pathologic stage of ypT0N+ rectal cancers following neo-adjuvant treatment: clinical interpretation of an orphan status.
Lorenzon L; De Luca R; Santoro G; Parini D; Rega D; Mellano A; Vigorita V; Jiménez-Rosellón R; Sandin M; Andriola V; Gallo G; Marino G; Turati L; Marsanic P; Marano L; Lucarini A; Aprile A; Sagnotta A; Biondi A;
Pathol Res Pract; 2022 Sep; 237():154002. PubMed ID: 35849868
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes in ypT0 rectal cancers: An international multi-centric investigation on behalf of Italian Society of Surgical Oncology Young Board (YSICO).
Lorenzon L; Parini D; Rega D; Mellano A; Vigorita V; Biondi A; Jaminez-Rosellon R; Scheiterle M; Giannini I; Gallo G; Marino G; Turati L; Marsanic P; De Franco L; Marano L; ; De Luca R
Eur J Surg Oncol; 2017 Aug; 43(8):1472-1480. PubMed ID: 28571778
[TBL] [Abstract][Full Text] [Related]
3. Tailored selection of the interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer: analysis based on the pathologic stage or chemoradiation response.
You KY; Huang R; Zhang LN; Ding PR; Xiao WW; Qiu B; Chang H; Zeng ZF; Pan ZZ; Gao YH
J Cancer Res Clin Oncol; 2015 Apr; 141(4):719-28. PubMed ID: 25296560
[TBL] [Abstract][Full Text] [Related]
4. Impact of residual nodal involvement after complete tumor response in patients undergoing neoadjuvant (chemo)radiotherapy for rectal cancer.
Erkan A; Mendez A; Trepanier M; Kelly J; Nassif G; Albert MR; Lee L; Monson JRT
Surgery; 2019 Oct; 166(4):648-654. PubMed ID: 31378480
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
[TBL] [Abstract][Full Text] [Related]
6. Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01).
Yeo SG; Kim DY; Kim TH; Chang HJ; Oh JH; Park W; Choi DH; Nam H; Kim JS; Cho MJ; Kim JH; Park JH; Kang MK; Koom WS; Kim JS; Nam TK; Chie EK; Kim JS; Lee KJ
Ann Surg; 2010 Dec; 252(6):998-1004. PubMed ID: 21107110
[TBL] [Abstract][Full Text] [Related]
7. Global variation in the long-term outcomes of ypT0 rectal cancers.
Lorenzon L; Evrard S; Beets G; Gonzalez-Moreno S; Kovacs T; D'Ugo D; Polom K;
Eur J Surg Oncol; 2020 Mar; 46(3):420-428. PubMed ID: 31733929
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy.
Wen B; Zhang L; Wang C; Huang R; Peng H; Zhang T; Dong J; Xiao W; Zeng Z; Liu M; Gao Y
Radiat Oncol; 2015 Jun; 10():124. PubMed ID: 26040453
[TBL] [Abstract][Full Text] [Related]
9. Poorer Oncologic Outcome of Good Responders to PCRT With Remnant Lymph Nodes Defies the Oncologic Paradox in Patients With Rectal Cancer.
Cho E; Park IJ; Hong SM; Lee JL; Kim CW; Yoon YS; Lim SB; Yu CS; Kim JC
Clin Colorectal Cancer; 2019 Jun; 18(2):e171-e178. PubMed ID: 31027968
[TBL] [Abstract][Full Text] [Related]
10. Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study.
Liao YT; Lin YL; Huang J; Hung JS; Lin BR
Int J Colorectal Dis; 2021 Mar; 36(3):509-516. PubMed ID: 33128083
[TBL] [Abstract][Full Text] [Related]
11. Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup.
Sprenger T; Rothe H; Conradi LC; Beissbarth T; Kauffels A; Kitz J; Homayounfar K; Wolff H; Ströbel P; Ghadimi M; Wittekind C; Sauer R; Rödel C; Liersch T
Dis Colon Rectum; 2016 May; 59(5):377-85. PubMed ID: 27050599
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
Park IJ; You YN; Skibber JM; Rodriguez-Bigas MA; Feig B; Nguyen S; Hu CY; Chang GJ
Dis Colon Rectum; 2013 Feb; 56(2):135-41. PubMed ID: 23303140
[TBL] [Abstract][Full Text] [Related]
13. The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy.
Ahn DH; Wu C; Wei L; Williams TM; Wuthrick E; Abdel-Misih S; Harzman A; Husain S; Schmidt C; Goldberg RM; Bekaii-Saab T
Am J Clin Oncol; 2017 Dec; 40(6):531-534. PubMed ID: 25723741
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
[TBL] [Abstract][Full Text] [Related]
15. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
[TBL] [Abstract][Full Text] [Related]
16. Oncologic Safety of Local Excision Compared With Total Mesorectal Excision for ypT0-T1 Rectal Cancer: A Propensity Score Analysis.
Jung SM; Yu CS; Park IJ; Kim TW; Kim JH; Yoon YS; Lim SB; Kim JC
Medicine (Baltimore); 2016 May; 95(20):e3718. PubMed ID: 27196490
[TBL] [Abstract][Full Text] [Related]
17. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
[TBL] [Abstract][Full Text] [Related]
18. Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery.
Kim CG; Ahn JB; Shin SJ; Beom SH; Heo SJ; Park HS; Kim JH; Choe EA; Koom WS; Hur H; Min BS; Kim NK; Kim H; Kim C; Jung I; Jung M
BMC Cancer; 2017 Sep; 17(1):615. PubMed ID: 28865435
[TBL] [Abstract][Full Text] [Related]
19. Impact of adjuvant chemotherapy on patients with ypT0-2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital.
Galata C; Merx K; Mai S; Gaiser T; Wenz F; Post S; Kienle P; Hofheinz RD; Horisberger K
World J Surg Oncol; 2018 Aug; 16(1):156. PubMed ID: 30071852
[TBL] [Abstract][Full Text] [Related]
20. What is the incidence of metastatic lymph node involvement after significant pathologic response of primary tumor following neoadjuvant treatment for locally advanced rectal cancer?
Tranchart H; Lefèvre JH; Svrcek M; Flejou JF; Tiret E; Parc Y
Ann Surg Oncol; 2013 May; 20(5):1551-9. PubMed ID: 23188545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
